New approaches to biochemical radioprotection:  antioxidants and DNA repair enhancement.
Chemical repair may be provided by radioprotective compounds present during exposure to ionizing radiation.  Considering DNA as the most sensitive target it is feasible to biochemically improve protection by enhancing DNA repair mechanisms.  Protection of DNA by reducing the amount of damage (by radical scavenging and chemical repair) followed by enhanced repair of DNA will provide much improved protection and recovery.  Furthermore, in cases of prolonged exposure, such as is possible in prolonged space missions, or of unexpected variations in the intensity of radiation, as is possible when encountering solar flares, it is important to provide long-acting protection, and this may be provided by antioxidants and well functioning DNA repair systems.  It has also become important to provide protection from the potentially damaging action of long-lived clastogenic factors which have been found in plasma of exposed persons from Hiroshima & Nagasaki, radiation accidents, radiotherapy patients and recently in "liquidators"--persons involved in salvage operations at the Chernobyl reactor.  The clastogenic factor, which causes chromatid breaks in non-exposed plasma, might account for late effects and is posing a potential carcinogenic hazard.  The enzyme superoxide dismutase (SOD) has been shown to eliminate the breakage factor from cultured plasma of exposed persons.  Several compounds have been shown to enhance DNA repair:  WR-2721, nicotinamide, glutathione monoester (Riklis et al., unpublished) and others.  The right combination of such compounds may prove effective in providing protection from a wide range of radiation exposures over a long period of time.
Riklis
E
E
Nuclear Research Center-Negev, Beer Sheva, Israel.
Emerit
I
I
Setlow
R B
RB
D000975:Antioxidants / Q000494:pharmacology*; D004260:DNA Repair / Q000187:drug effects* / Q000502:physiology; D005609:Free Radicals / Q000009:adverse effects; D005978:Glutathione / Q000494:pharmacology; D009381:Neoplasms, Radiation-Induced / Q000209:etiology / Q000517:prevention & control; D011839:Radiation, Ionizing; D011837:Radiation-Protective Agents / Q000494:pharmacology*; D017382:Reactive Oxygen Species / Q000009:adverse effects; D013482:Superoxide Dismutase / Q000494:pharmacology
D000975:Antioxidants; D005609:Free Radicals; D011837:Radiation-Protective Agents; D017382:Reactive Oxygen Species; D013482:Superoxide Dismutase; D005978:Glutathione